Protective effects of Ginkgo biloba extract on cerebral ischemia and the responses of CD11b-immunoreactivity positive cells
Zhao-yang Xiao,Chang-kai Sun,Xu-wu Xiao,Yong-zhong Lin,Yu-ying Tong,Hui Ma,Gui-rong Song,Ran Cheng
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.43.017
2006-01-01
Abstract:AIM: To observe the neuroprotective effects of Ginkgo biloba extract (GBE) on mice focal cerebral ischemia and the responses of CD11b-immunoreactivity (CD11b-IR) positive cell. METHODS: The experiment was conducted in the Institutes for Brain Disorder, Dalian Medical University from March to June 2005. With the randomized controlled method, 120 Balb/c mice were divided into six groups: control group, illumination for 30 minutes group, rose begnal group, ischemia group, GBE pretreatment group, and Dexamethasone (DEX) treatment group with 20 mice in each group. GBE was pretreated with intraperitoneal doses of 100 mg/kg per day for 7 days to establish mice models of focal cerebral ischemia with photochemistry method. Movement Capture Analysis was used to evaluate the motion ability of mice models; the animals were killed (5 mice at each time point) at different time points (3 hours, 1, 3, and 7 days), and 2, 3, 5-triphenyltetrazolium chloride was used to observe the infarction volume; Nissl staining was adopted to observe the histological changes, and microglia response was assessed by immunohistochemistry of CD11b. RESULTS: All the 120 mice were involved in the result analysis without supplement. ①Compared with the control group, the average height in bilateral forelimbs and hindlimbs after ischemia for 1 day of the ischemia group was higher [(0.292 1±0.067 4), (0.174 0±0.05 3) cm, P < 0.001, P < 0.01], and GBE pretreatment and DEX treatment could significantly decrease the difference. ②After 24 hours of focal infarction ischemia, compared with the ischemia group, a significant reduction of infarction volume was found in the GBE pretreatment group and DEX group [(9.89±1.01), (7.23±1.45), (6.99±1.21) mm3, P < 0.01]. ③Nissl staining revealed that the number of neurons was increased in the lesion periphery of ischemia (P < 0.01). ④The number of positive CD11b-IR significantly reduced (P < 0.001) and the main gray (P < 0.001) of CD11b-IR in the lesion periphery of ischemia was increased after ischemia 1, 3 and 7 days. There was no significant difference in every index between GBE pretreatment group and DEX treatment group. CONCLUSION: GBE exerts neuroprotection after focal cerebral ischemia through inhibiting the response of microglia in brain.